GENERATIVE FORMULATIONS

Serial Number 87695286
606

Registration Progress

Application Filed
Nov 22, 2017
Under Examination
Jun 12, 2018
Approved for Publication
Apr 17, 2018
Published for Opposition
Apr 17, 2018
Registered

Basic Information

Serial Number
87695286
Filing Date
November 22, 2017
Published for Opposition
April 17, 2018
Abandonment Date
July 19, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 19, 2021
Classes
005

Rights Holder

North American Pharmacal, Inc.

03
Address
149 Water Street
Norwalk, CT 06854

Ownership History

North American Pharmacal, Inc.

Original Applicant
03
Norwalk, CT

North American Pharmacal, Inc.

Owner at Publication
03
Norwalk, CT

Legal Representation

Attorney
Stephen P. McNamara
USPTO Deadlines 3 active 3 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
EXAMINER AMENDMENT
Examiner's Amendment Completed
CNEA Mar 22, 2018 2664 days overdue Low No
OPPOSITION
Notice of Publication
NPUB May 17, 2018 2608 days overdue Medium Until Jun 17, 2018
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Dec 12, 2018 2399 days overdue High Until Jun 12, 2019

Application History

36 events
Date Code Type Description
Jul 19, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 19, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 1, 2020 EX5G S SOU EXTENSION 5 GRANTED
Nov 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 17, 2020 EXT5 S SOU EXTENSION 5 FILED
Jun 16, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 12, 2020 EXT4 S SOU EXTENSION 4 FILED
Jun 12, 2020 EX4G S SOU EXTENSION 4 GRANTED
Dec 14, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 12, 2019 EXT3 S SOU EXTENSION 3 FILED
Dec 12, 2019 EX3G S SOU EXTENSION 3 GRANTED
Jun 14, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 12, 2019 EXT2 S SOU EXTENSION 2 FILED
Jun 12, 2019 EX2G S SOU EXTENSION 2 GRANTED
Dec 13, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 11, 2018 EXT1 S SOU EXTENSION 1 FILED
Dec 11, 2018 EX1G S SOU EXTENSION 1 GRANTED
Jun 12, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 17, 2018 PUBO A PUBLISHED FOR OPPOSITION
Apr 17, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2018 ALIE A ASSIGNED TO LIE
Mar 7, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN
Mar 7, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED
Mar 7, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 7, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 7, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2018 DOCK D ASSIGNED TO EXAMINER
Dec 5, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Dietary supplements; Nutritional supplements
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"FORMULATIONS"